9
th
ANNUAL
EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITION 15th-16th MARCH 2016 for Partnering and Investing in Biotech & Pharma Industry Hilton Zurich Airport Hotel
Day One - 15th of March 08:00
Registration & Coffee
08:20
Welcome Speech by Leonard Sachs, Managing Director, Sachs Associates Ltd. Public Markets and M&A Panel - Room Panorama
Chaired by: Stephanie Léouzon, Partner and Head of Europe, Torreya Partners (Europe), LLP Panellists: Christian Lach, Portfolio Manager, Bellevue Asset Management AG 08:30 Isabella Schidrich, Senior Managing Director, NASDAQ OMX Ivo Staijen, Investment Advisor, Portfolio Manager, HBM Partners AG James Sapirstein, CEO, ContraVir Pharmaceuticals, Inc. Mark Beards, Corporate Development Director, Cell Therapy Ltd. Thomas Stockman, Director, Healthcare Investment Banking, Royal Bank of Canada
Investment Panel - Room Panorama
Co-chaired by: Markus Goebel, Managing Director, Novartis Venture Fund Markus Hosang, General Partner and Managing Director, BioMedPartners AG Panellists: Arthur Franken, Partner, Gilde Healthcare 09:30 Cynthia Lavoie, General Partner, TVM Life Science Management, Inc. Lionel Carnot, Managing Director, Bay City Capital Margarita Chavez, Director, Ventures & Early Stage Collaborations, AbbVie, Inc. Matthew Foy, Partner, S.R.One Limited Michèle Ollier, Partner, Medicxi Ventures Naveed Siddiqi, Partner, Edmond de Rothschild Investment Partners Paul Hermant, Partner, Bird & Bird LLP 10:30
Coffee Break
Presentation Track A - Room Berne Moderated by: Joergen Thorball, XOventure GmbH 09:30
DC4U B.V.
09:40
Glide Pharmaceutical Technologies Limited
09:50
Marinomed Biotechnologie GmbH
10:00
[Available]
10:10
ATRIVA Therapeutics GmbH
10:20
EMTensor GmbH
9
th
ANNUAL
EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITION 15th-16th MARCH 2016 for Partnering and Investing in Biotech & Pharma Industry Hilton Zurich Airport Hotel Presentation Track B - Room Panorama B Moderated by: Hans Herklots, Capricorn One
Oncology I – Clinical Development and Regulation in Europe - Room Panorama A
Co-Chaired by: Esteban Pombo-Villar, Chief Operating Officer, Oxford BioTherapeutics, Inc. François Thomas, President, Inserm Transfert Initiative Panellists: 10:45 Eugen Leo, Senior Consultant, LEO Consulting Heinz Lubenau, General Manager and Head of Development, VAXIMM GmbH Mark Vaeck, CEO, Complix N.V. Richard Godfrey, CEO, BerGenBio AS Simon Kerry, Chief Executive Officer, Karus Therapeutics Ltd.
10:45
Curetis N.V.
10:55
InnVentis Ltd.
11:05
Provista Diagnostics, Inc. Diagnostics & Imaging Panel
Oncology II - Innovation and BD&L - Room Panorama A
Co-Chaired by: Esteban Pombo-Villar, Chief Operating Officer, Oxford BioTherapeutics, Inc. Tim Herpin, Vice President, Head of Transactions (UK), AstraZeneca Panellists: 11:45 Anja König, Managing Director, Novartis Venture Fund David Malek, VP Business Development, BioLineRx Ltd. Guillaume Vignon, Director BD Oncology - Global BD and Licensing, EMD Serono Peter Hoang, SVP BD & Strategy, Bellicum Pharmaceuticals, Inc. Jason Slingsby, Head of Business Development, Oxford BioMedica Plc
Room Panorama A Interview with Laurent Audoly, SVP, Head of R&D, Managing Partner, 12:30 Global Head of Drug Development and Translational Medicine, Pierre Fabre Fund for Innovation by: Fintan Walton, CEO, PharmaVentures Ltd. 13:00
Networking Lunch
Chaired by: Beat Merz, Managing Director, Rockport Venture Partners Panellists: Ena Prosser, Partner, Fountain Healthcare Partners 11:30 David Reese, President and CEO, Provista Diagnostics, Inc. Oliver Schacht, CEO, Curetis N.V. Rainer Metzger, VP Head Precision Diagnostics and Pharma Partnering, QIAGEN GmbH Thierry Chignon, Senior Partner, Merieux Developpement SAS Thomas Wilckens, CEO, InnVentis Ltd.
Autoimmune & Infectious Diseases Panel
Chaired by: Regina Hodits, General Partner, Wellington Partners Panellists: 12:15 Dale Dhanoa, CEO, AKAAL Pharma Eric de La Fortelle, Venture Partner, Seventure Partners Markus Kalousek, Global BD&L Franchise Head, I&D, S&E, Novartis Pharma AG Simon Blake, Senior Director, Scientific Licensing for Immunology, J&J Pharmaceutical Research and Development
Presentation Track C - Room Berne Moderated by: TBA 10:45
Targovax ASA
11:00
ContraVir Pharmaceuticals, Inc.
11:15
Addex Therapeutics Ltd.
11:30
Cell Therapy Ltd.
11:45
Tissue Regenix Group Plc.
12:00
Eos Biosciences, Inc.
12:15
Inventiva Pharma
12:30
[Available]
12:45
ImmunID
9
th
ANNUAL
EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITION 15th-16th MARCH 2016 for Partnering and Investing in Biotech & Pharma Industry Hilton Zurich Airport Hotel Presentation Track D - Room Panorama B Moderated by: Bob Pooler, valuationLAB AG
Platform Technologies & Novel Therapeutics Panel
Co-Chaired by: Chandra Leo, Partner, HBM Partners AG Heinz Schwer, CEO, Lanthio Pharma B.V. Panellists: Anker Lundemose, CEO, MISSION Therapeutics Ltd. 14:00 Christophe Bonny, CSO, Bicycle Therapeutics Limited David Urech, Co-CEO & CSO, Numab AG Dieter Ziegler, Director - Search and Evaluation Europe, AbbVie, Inc. Laurent Audoly, SVP, Head of R&D, Managing Partner, Global Head of Drug Development and Translational Medicine, Pierre Fabre Fund for Innovation Mark Carnegie-Brown, CEO, Glide Pharmaceutical Technologies Limited
Innovation Panel
Co-Chaired by: Matthias Bünte, Partner, Ernst & Young AG Rao Movva, Novartis Distinguished Scientist, Novartis Institutes for BioMedical Research Panellists: Bill Blair, Director of Company Creation, Sunergos Innovations 14:45 Ernst Hafen, President, Bio-Technopark Schlieren-Zurich Fabian Buller, Director, New Ventures, Johnson & Johnson Innovation François Thomas, President, Inserm Transfert Initiative Joern-Peter Halle, SVP, Head of External Innovation, Biopharma, Global Research & Development, Merck KGaA Ulrich Muehlner, Global Head Outcomes Technologies Incubator (NOVAE), Novartis Pharma AG 15:45
Coffee Break
14:00
14:15
14:30
14:45
OSE Pharma
BioLineRx Ltd.
Karus Therapeutics Ltd.
14:00
amcure GmbH
14:10
BioSight Ltd.
14:20
INOFEA AG
14:30
Pragma Therapeutics
14:40
Therabron Therapeutics, Inc.
14:50
Athera Biotechnologies AB
15:00
GreenBone Ortho srl
15:10
Cellestia Biotech AG
15:25
MedLumics S.L.
15:35
Virometix AG
Avexxin AS
15:00
Helsinn Healthcare SA
15:15
[Reserved]
15:30
Presentation Track E - Room Berne Moderated by: Hans Herklots, Capricorn One
Abzena Plc
9
th
ANNUAL
EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITION 15th-16th MARCH 2016 for Partnering and Investing in Biotech & Pharma Industry Hilton Zurich Airport Hotel Presentation Track F - Room Panorama B Moderated by: Bruno Bulic, Helvea Baader Bank
Neuroscience Panel
Chaired by: Charles Bailey, Head of Search & Evaluation, Neurosciences, Novartis Pharma AG Panellists: Jennifer Laird, Senior Director, Search & Evaluation, Eli Lilly & Co. 16:00 Klaus Mendla, Global Head, CNS BD and Licensing, Boehringer Ingelheim Pharma GmbH & Co. KG Laurence Barker, Dementia Discovery Fund CBO, SV Life Sciences Pierandrea Muglia, VP, Head Neuroscience Discovery, UCB Pharma Rosa Sancho, Head of Research, Alzheimer's Research UK Tim Dyer, CEO, Addex Therapeutics Ltd.
Early Stage Investment Panel
Chaired by: Hakan Goker, Senior Investment Director, MS Ventures Panellists: Carina Schmidt, CEO, Athera Biotechnologies AB Jonathan Tobin, Principal, Healthcare Ventures, Imperial Innovations 17:00 Karl Nägler, Partner, Gimv Lars Gredsted, Senior Business Analyst, Wellcome Trust Luc Otten, Business Development, The Alpine Institute for Drug Discovery Martin Pfister, Senior Investment Manager, High-Tech-Gruenderfonds Management GmbH Nanna Luneborg, Principal, Novo Ventures Reza Halse, Head of MSD European Innovation Hub, MSD
18:00
Networking Reception
20:00
End of Reception & Day One
16:00
Vaximm AG
16:15
Oxford BioMedica Plc
16:30
BerGenBio AS
16:45
MISSION Therapeutics Ltd.
17:00
Numab AG
17:15
Bicycle Therapeutics Limited
17:30
Canbex Therapeutics Ltd.
17:45
[Available]
Presentation Track G - Room Berne Moderated by: TBA 16:00
APIM Therapeutics AS
16:10
LeukoDx Ltd.
16:20
Akaal Pharma Pty Ltd.
16:30
Inflamalps SA
16:40
Strekin AG
16:50
TaiwanJ Pharmaceuticals
17:00
Zytoprotec GmbH
17:10
Cellply s.r.l.
17:20
[Available]
17:30
[Available]
17:40
[Available]
17:50
[Available]
9
th
ANNUAL
EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITION 15th-16th MARCH 2016 for Partnering and Investing in Biotech & Pharma Industry Hilton Zurich Airport Hotel
Day Two - 16th of March 08:00
Registration & Coffee Partnering Panel Session I – “How to win the big deal with pharmaceutical companies in a competitive market”
Co-Chaired by: David Colpman, Director, Colpman Consulting Ltd. Fintan Walton, CEO, PharmaVentures Ltd. Panellists: 09:00 Lubor Gaal, Head of Licensing and External Innovation, Almirall S.A. Martin E. Judge, Innovation Sourcing Director, Novo Nordisk Paola Casarosa, Corp. VP, Business Development & Licensing/Prescription Medicines, Boehringer Ingelheim GmbH Patrick Benz, Senior Director Alliance Management, Johnson & Johnson Innovation - JJDC, Inc. Uwe Schoenbeck, SVP & Chief Scientific Officer, External R&D, Pfizer, Inc.
Presentation Track A - Room Berne Moderated by: Joergen Thorball, XOventure GmbH
Partnering Panel Session II – “The art of creative deal structures in licensing and partnering agreements”
Co-Chaired by: Chris Britten, Managing Director, Torreya Partners (Europe), LLP Fintan Walton, CEO, PharmaVentures Ltd. Panellists: 09:45 Norbert Steinbach, Director Business Development Western Europe & Canada, AbbVie Inc. Sarah Holland, Head of Europe, External Science and Partnering, Sanofi Sandra Nobre, Senior Director Business Development, Takeda Pharmaceuticals International GmbH Stewart Kay, Director Transactions, GlaxoSmithKline Plc Will Watson, Head of European Business Development, Teva Pharmaceutical Industries Ltd.
10:30
10:45
“Secure Data for Biopharmaceutical Companies” presentation by: Luisa Henk, Senior Manager Business Development, Drooms AG
Coffee Break
09:45
ProAxsis Ltd.
09:55
Stratpharma AG
10:05
Medimetrics Personalized Drug Delivery B.V.
10:15
MyoPowers Medical Technologies France SAS
10:25
Genetics Microdevices Ltd.
10:35
seiratherm GmbH
Presentation Track B - Room Berne Moderated by: Vincent Ossipow, Omega Funds
“AM-Pharma – Pfizer: A Collaboration Preparing for Success”
11:00 Erik van den Berg, CEO, AM-Pharma B.V. Uwe Schoenbeck, SVP & Chief Scientific Officer, External R&D, Pfizer, Inc.
Israel Panel
Chaired by: Laurent Choppe, Managing Partner, Cukierman & Co. Life Sciences Panellists: 11:15 Dan Gelvan, Managing Director, Aurum Ventures MKI Ltd. Ittai Harel, Managing General Partner, Pitango Venture Capital Michal Silverberg, Senior Director, External Innovations Israel and Europe, Takeda Pharmaceuticals International GmbH Ruth Ben Yakar, CEO, BioSight Ltd.
Speech: “Top Stories and Technologies to Watch in Medtech” by:
12:00 David Cassak, Managing Partner, Innovation in Medtech, LLC Stephen Levin, Managing Partner, Innovation in Medtech, LLC
MedTech and Digital Health Panel
Co-Chaired by: David Cassak, Managing Partner, Innovation in Medtech, LLC Stephen Levin, Managing Partner, Innovation in Medtech, LLC Panellists: 12:20 Bart de Witte, Healthcare Industry Leader DACH, IBM Eric Rambeaux, CEO, MyoPowers Medical Technologies France SAS Geoff Cumming, CEO, Anteo Diagnostics Ltd. Jennifer McMahon, Associate, Seroba Life Sciences Peter Langkafel, CEO, HCB Healthcubator GmbH Yves Decadt, CEO, Medimetrics Personalized Medicine 13:00
11:00
Provectus Biopharmaceuticals, Inc.
11:15
Sophia Genetics
11:30
Anteo Diagnostics Ltd.
11:45
Xeltis AG
12:00
Vaxart, Inc.
12:15
MorphoSys AG
12:30
InGeneron GmbH
12:45
[Available]
Networking Lunch Workshop: "How to win or avoid IP and licensing disputes. - An assessment of mistakes made by losers” by:
14:00 Fintan Walton, CEO and Nigel Borshell, VP at PharmaVentures Ltd. 15:30
Last Chance to Network
16:00
End of the Forum
